TotalMarketCap

Genmab A/S

GMABNasdaq DenmarkHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$32.988 B

$52.86 -4.10%

Close of 6 Nov 2026

As of 6 Nov 2026, Genmab A/S (GMAB) has a market capitalization of $33.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #18Royalty PharmaRPRX$38.9B
  2. #19ZoetisZTS$33.9B
  3. #20Genmab A/SGMAB$33.0B
  4. #21Roivant SciencesROIV$26.5B
  5. #22United TherapeuticsUTHR$24.1B

What if Genmab A/S were worth as much as…

Open the what-if tool →

Gold $28.2T

$45,247.15

Per share 856× higher

Bitcoin $1.53T

$2,448.24

Per share 46.3× higher

Apple $5.02T

$8,037.36

Per share 152× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Genmab A/S are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.